May 14, 2020

PolitiFact and MediaWise are teaming up to debunk misinformation about the coronavirus crisis. To have Coronavirus Facts delivered to your inbox Monday-Friday, click here.

Americans are counting on a safe and effective vaccine against the novel coronavirus. Two months into the pandemic, is the U.S. and the world any closer to one?

The short answer is yes, experts say. But creating an effective vaccine will still require a lot to go right.

There are more than 100 vaccine projects underway worldwide, according to the World Health Organization. At least eight of them have moved to the early clinical trial phase. Four of these vaccines were created in China, one in the U.K, one in the European Union, and two in the United States. Others could move to clinical trials in the coming months.

Having so many potential vaccines in the testing phase is impressive, experts say, considering the short time scientists have known about the novel coronavirus.

“Multiple groups from government, industry, and academia have come together to forge partnerships that advance candidate vaccines,” said Matthew B. Laurens, an associate professor of pediatrics at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health. “The shift from other research activities to this urgent public health crisis is both encouraging and exactly what needs to happen.”

In early April, Kathleen M. Neuzil, director of the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, told PolitiFact that if all went well, there might be five or six vaccines in trials within six months. Five weeks later, there are already more than that undergoing trials.

Officials including Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, have remained consistent in their estimation of the timeline for creating a workable vaccine: 12 to 18 months. That’s a much shorter time frame than for previous vaccines, which have taken between four years and several decades. But given the intense pressure of the coronavirus pandemic, standard development and production models are being telescoped.

Here’s the state of play on coronavirus vaccine research, and how developments in the past two months have changed the outlook.

Click here to read more.

These teenagers are tackling coronavirus misinformation

Schools are closed, and students are home. What do teens do during a pandemic? In Take on Fake, a new YouTube series hosted by Hari Sreenivasan, MediaWise teen fact-checker Angela Li walks you through how she investigated a viral TikTok video in the midst of the COVID-19 pandemic. Watch Take on Fake»

Tweet claims HPV vaccine deadlier than COVID-19

State Rep. Jeff Shipley wrote that young people have a higher risk of dying from the HPV vaccination than of COVID-19. No deaths have ever been linked to the HPV vaccine. Read the fact-check»

Three tips to fact-check COVID-19 claims

Don’t get caught up with misinformation. Here’s how to evaluate information before sharing online. Watch the tips»

Should you be wearing gloves in public?

No. Health experts say the general public should not wear gloves. Get the facts»

Click here to get this newsletter in your inbox every weekday.

Alex Mahadevan is a senior multimedia reporter at MediaWise. He can be reached at amahadevan@poynter.org or on Twitter at @AlexMahadevan. Follow MediaWise on TikTok.

Support high-integrity, independent journalism that serves democracy. Make a gift to Poynter today. The Poynter Institute is a nonpartisan, nonprofit organization, and your gift helps us make good journalism better.
Donate
Alex Mahadevan is director of MediaWise, Poynter’s digital media literacy project that teaches people of all ages how to spot misinformation online. As director, Alex…
Alex Mahadevan
Louis Jacobson has been with PolitiFact since 2009, currently as chief correspondent. Previously, he served as senior correspondent and deputy editor. Before joining PolitiFact, he…
Louis Jacobson

More News

Back to News